ÂÜÀòÂÒÂ×

Sheli Goldstein is a Senior Analyst at The Dedham Group, a position held since June 2024. Previously, Sheli served as a Senior Analyst and Analyst in Market Access at Envision Pharma Group from August 2021 to May 2024. Additionally, a Clinical Business Operations Co-op role was completed at bluebird bio from July 2020 to June 2021, and Sheli worked as a Clinical Research Coordinator at Massachusetts Eye and Ear from July 2019 to December 2019. Educationally, Sheli holds a B.S. in Health Science and Business Administration from Northeastern University.